Correlation Between Inozyme Pharma and NRX Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and NRX Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and NRX Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and NRX Pharmaceuticals, you can compare the effects of market volatilities on Inozyme Pharma and NRX Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of NRX Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and NRX Pharmaceuticals.

Diversification Opportunities for Inozyme Pharma and NRX Pharmaceuticals

InozymeNRXDiversified AwayInozymeNRXDiversified Away100%
-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Inozyme and NRX is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and NRX Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRX Pharmaceuticals and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with NRX Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRX Pharmaceuticals has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and NRX Pharmaceuticals go up and down completely randomly.

Pair Corralation between Inozyme Pharma and NRX Pharmaceuticals

Given the investment horizon of 90 days Inozyme Pharma is expected to generate 0.63 times more return on investment than NRX Pharmaceuticals. However, Inozyme Pharma is 1.58 times less risky than NRX Pharmaceuticals. It trades about -0.07 of its potential returns per unit of risk. NRX Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest  136.00  in Inozyme Pharma on November 27, 2024 and sell it today you would lose (12.00) from holding Inozyme Pharma or give up 8.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Inozyme Pharma  vs.  NRX Pharmaceuticals

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb 0100200300
JavaScript chart by amCharts 3.21.15INZY NRXP
       Timeline  
Inozyme Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb1.522.533.5
NRX Pharmaceuticals 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in NRX Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, NRX Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb23456

Inozyme Pharma and NRX Pharmaceuticals Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-10.56-7.91-5.26-2.610.02.14.276.448.6110.78 0.0040.0060.0080.010
JavaScript chart by amCharts 3.21.15INZY NRXP
       Returns  

Pair Trading with Inozyme Pharma and NRX Pharmaceuticals

The main advantage of trading using opposite Inozyme Pharma and NRX Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, NRX Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRX Pharmaceuticals will offset losses from the drop in NRX Pharmaceuticals' long position.
The idea behind Inozyme Pharma and NRX Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data